Antibiotics
Código 2941 (Harmonized System 2012 by 4 digits)
2023: US$266M, Total Trade Exchange
2023: US$68.4M, International Sales
2023: US$198M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Antibiotics was US$266M.
In 2023, the states with the most international sales in Antibiotics were Estado de México (US$9.25M), Ciudad de México (US$320k), and Jalisco (US$70.7k).
The states with the most international purchases in 2023 were Jalisco (US$98.5M), Ciudad de México (US$54.4M), Estado de México (US$32.4M), Guanajuato (US$4.88M), and Coahuila de Zaragoza (US$2.23M).
In 2023, the main commercial destinations of Antibiotics were Spain (US$3.65M), Turkey (US$1.35M), Russia (US$702k), Brazil (US$609k), and Switzerland (US$574k).
The main commercial origins of Antibiotics in 2023 were China (US$114M), India (US$25.6M), Spain (US$18.3M), Italy (US$10.3M), and Ireland (US$5.48M).
In the global context, the main exporting countries of Antibiotics in 2022 were China (US$4.73B), India (US$885M), and Italy (US$833M). In the same year, the main importing countries of Antibiotics were India (US$1.57B), Italy (US$1.01B), and Germany (US$663M).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionUS$266M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Antibiotics in Mexico (including international purchases and sales) was US$266M.
The visualizations show the net balance of Antibiotics at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionNovember, 2024
- US$13.6M, International Purchases
- US$8.72M, International Sales
In November 2024, international sales of Antibiotics were US$8.72M, while international purchases reached US$13.6M. The above results in a trade balance of -US$4.85M.
Market Concentration
#permalink to section2024-Q4: US$1.07M, International Sales
The visualization shows the quarterly concentration of international sales of Antibiotics at state level.
In the fourth quarter of 2024, international sales were US$1.07M, being the states with the most sales Estado de México (US$1.07M).
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionEstado de México: US$9.25M, State with the Most International Sales (2023)
Spain: US$3.65M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Antibiotics were Estado de México (US$9.25M), Ciudad de México (US$320k), and Jalisco (US$70.7k).
In 2023, the countries with the most international purchases from Mexico were Spain (US$3.65M), Turkey (US$1.35M), Russia (US$702k), Brazil (US$609k), and Switzerland (US$574k).
International Purchases
#permalink to sectionJalisco: US$98.5M, State with the Most International Purchases (2023)
China: US$114M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Antibiotics were Jalisco (US$98.5M), Ciudad de México (US$54.4M), Estado de México (US$32.4M), Guanajuato (US$4.88M), and Coahuila de Zaragoza (US$2.23M).
The countries with the most international sales to Mexico in 2023 were China (US$114M), India (US$25.6M), Spain (US$18.3M), Italy (US$10.3M), and Ireland (US$5.48M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Antibiotics and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Antibiotics. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.75%, Mexican share in global exports - 2022
- 1.86%, Mexican share in global imports - 2022
The visualizations show the global market for Antibiotics. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Antibiotics were China (US$4.73B), India (US$885M), and Italy (US$833M). In the same year, the main importing countries for Antibiotics were India (US$1.57B), Italy (US$1.01B), and Germany (US$663M).